Introduction:
Subacromial injection is considered one of the best treatments for patients with subacromial
impingement syndrome. The subacromial bursa is located between the deltoid muscle and the
supraspinatus tendon. It facilitates the gliding of the humeral head through the undersurface
of the acromion. If the bursa is thickened, the patient may experience pain when he/she tries
to raise the arm. In patients with subacromial impingement due to a thickened subacromial
bursa, the physician can precisely inject the medication into the bursa using ultrasound
guidance. Use of ultrasound guidance has been proven to yield a better effect of pain relief
than the technique using guidance. A previous study found that even using ultrasound guidance
to deliver medication, there were still many patients suffering from initial treatment
failure or recurrence after the first successful injection. Because the pathophysiological
mechanism of subacromial impingement is complexed, the proximal biceps tendon may be involved
but is often ignored. Recently, the investigators published a randomized controlled trial
comparing the effect of dual-target injection (proximal biceps tendon and subacromial bursa)
with the standard subacromial injection in patients with subacromial impingement syndrome,
and found that the dual target approach was safe and had a longer effective duration than the
standard subacromial injection. In this regard, the investigators will conduct a longitudinal
follow-up study to examine the long-term effectiveness of the dual-target corticosteroid
injection for subacromial impingement syndrome.
Material and methods:
Participants: adult patients (>20 year old) with shoulder impingement syndrome Inclusion
criteria: shoulder pain>3 weeks; no contraindication for local injection; Visual analogue
scale of pain>4 The healthy volunteers are defined as no shoulder pain, and are only for the
assessment of the inter-rater and intra-rater reliability of the ultrasound evaluation,
without intervention
Participant number: 210 (150 with subacromial impingement, and 60 of healthy subjects)
Exclusion criteria: systemic rheumatologic disease, Ankylosing spondylitis, malignancy, major
trauma or recent injections on the affected shoulder
Study design:
The aims of this study is (1) set up the inter-rater and intra-rater reliability of the
ultrasound evaluation in patients with subacromial impingement and healthy subjects (2)
longitudinal follow up the therapeutic effect of dual-target injection to subacromial bursa
and biceps tendon sheath only in patients with subacromial impingement
Detail of the intervention Single arm experiment: ultrasound guided injection into the
subacromial bursa and biceps tendon sheath in patients with subacromial impingements, with 40
mg triamcinolone acetonide plus 3 mL of lidocaine
Outcome measurement:
physical examination(bicipital groove compression test, Speed's test, Yergason's test, empty
can test, Neer's impingement test, Hawkins-Kennedy impingement test, painful arc test), range
of motion as the baseline information. Visual analogue scale of pain, shoulder pain and
disability index (SPADI), shoulder sonography (gray-scale/elastography)
Statistical analysis:
Continuous variables
Student's t test: fit assumption of normal distribution
Mann-Whitney test: does not fit the assumption of normal distribution
Categorical variables
(1) Chi-square test (2) Fisher exact test: sparse data
Multivariate analysis:
Linear regression
Logistic regression
Keywords: ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain,
longitudinal follow-up